Dr. Eileen Rakovitch
MD, FRCP(C), M.Sc.
Sunnybrook Research Institute
DCIS, or ductal carcinoma in situ, is a non-invasive form of breast cancer. It is unlikely for DCIS to be fatal; however, in some cases DCIS can come back and at times, come back as an invasive form of breast cancer. It’s important for patients diagnosed with DCIS to have as much information as possible: educate themselves and make an informed decision on what types of treatment best suit their individual case. There is a new method of determining a patient’s specific risk of recurrence. With the latest advances in genomic testing, physicians and their patients now have the opportunity to equip themselves with more precise information to be able to guide treatment selection.
View the shorter version of this video here